Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed monotherapy in platinum-resistant head and neck cancer
NCT01333696Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Apr 2011
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in head and neck squamous cell carcinoma (HNSCC), sponsored by Fudan University. Status: unknown.
02
Drugs
pemetrexed
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01333696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333696.